Latest News

Amino acid offers potential therapeutic alternative in psychiatric disorders

Improved understanding of the roles of inflammation and oxidative stress in psychiatric disorders has generated new leads in the search for novel therapies. One such investigative compound currently in clinical trials is an amino acid, N-Acetyl Cysteine (NAC), which appears to reduce the core symptoms of bipolar disorder, schizophrenia, depression, autism and cravings in addictions including cocaine, cannabis abuse and cigarette smoking.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Medicinal marijuana: Patients battle stigma and misunderstanding

  • CPR: It's not always a lifesaver, but it plays one on TV

  • Goth teens could be more vulnerable to depression and self-harm

  • Brain scans predict response to antipsychotic medications

  • Older adults possess important forms of expertise

  • Covert and overt forms of sexism are equally damaging to working women

  • Retinoids may increase effectiveness of targeted therapies against high-risk leukemia

  • Air pollution linked to children's low academic achievement

  • Turning breath into words: New device unveiled to give paralysis victims a voice

  • Neurobiology: Light-activated learning

  •